ExpLanation
Increaseheriskofdoting
Raloxifeneisaselectiveoestroqen-receptor modulatorthat exerts both oestroaen-aaonisteffectson boneand
Uijpid metabouismandoestrogen-antaaonisteffectsonuterineendometriumandbreasttissue
Themostcommonadverseeffectsof raloifenearehotftushes and ueqcramps.Thereis alsoan
increasedriskofclots
Beneficiateffects:ThebeneficiaLoestrogenicactivities ofraloxifeneincludealowveringoftotatand low
densityuipoproteincholesteroLlevelsandimprovement
bonemineraL densityRaloxifenereduces
fractureriskatthespinebutnotatthehip.Inwomen withapreviousvertebraufracture,themagnitude
ofthisreductionhasbeenfoundtobedose-dependemt and atleastfourtimes greater in wvomen with
no previous fracture.
Raloxifenevsoestroqen:Raloxifenedoesnotraisetrialvycerideor hiah-densityuipoprotein(HDL)
cholesteroLueveLs.tdoesnothavesomeofthetroublesomeside-effectsofoestrogem.such asvagina
spottina(bleedina)orbreasttenderness.Raloxifenemiahthavefewer side-effectsthanaretvpicaU
observedwithoestroqentherapy becauseofitstissue selectivitv
@1MINNDOCRINE
